Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
American Journal of Rhinology
|
January 1, 1997
Follow-up of University of Virginia experience with the modified Lothrop procedure
C W Gross, G C Zachmann, D G Becker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma
R Pazdur, D F Moore, B Bready, et al.
The Western Journal of Medicine
|
October 1, 1992
Isolation of Borrelia burgdorferi from ticks in southern California
H B Meyers, D F Moore, G Gellert, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 1, 1995
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study
D F Moore, F Swan, J Yau, et al.
Leukemia & Lymphoma
|
August 26, 1998
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)
P H Wiernik, D F Moore, J M Bennett, et al.
Prostate Cancer and Prostatic Diseases
|
June 24, 2015
Primary radiotherapy vs conservative management for localized prostate cancer--a population-based study
G L Lu-Yao, S Kim, D F Moore, et al.
Brain : a Journal of Neurology
|
November 16, 2006
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease
M Ries, H J Kim, C K Zalewski, et al.
Investigational New Drugs
|
January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas
J E Romaguera, M A Rodriguez, F B Hagemeister, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 15, 2020
5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial
Matthew M Poppe, Zeinab A Yehia, Christopher Baker, et al.
Investigational New Drugs
|
July 30, 1999
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma
R Pazdur, D C Medgyesy, R J Winn, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
American Journal of Rhinology
|
January 1, 1997
Follow-up of University of Virginia experience with the modified Lothrop procedure
C W Gross, G C Zachmann, D G Becker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma
R Pazdur, D F Moore, B Bready, et al.
The Western Journal of Medicine
|
October 1, 1992
Isolation of Borrelia burgdorferi from ticks in southern California
H B Meyers, D F Moore, G Gellert, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 1, 1995
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study
D F Moore, F Swan, J Yau, et al.
Leukemia & Lymphoma
|
August 26, 1998
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)
P H Wiernik, D F Moore, J M Bennett, et al.
Prostate Cancer and Prostatic Diseases
|
June 24, 2015
Primary radiotherapy vs conservative management for localized prostate cancer--a population-based study
G L Lu-Yao, S Kim, D F Moore, et al.
Brain : a Journal of Neurology
|
November 16, 2006
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease
M Ries, H J Kim, C K Zalewski, et al.
Investigational New Drugs
|
January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas
J E Romaguera, M A Rodriguez, F B Hagemeister, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 15, 2020
5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial
Matthew M Poppe, Zeinab A Yehia, Christopher Baker, et al.
Investigational New Drugs
|
July 30, 1999
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma
R Pazdur, D C Medgyesy, R J Winn, et al.
Page
of 11